Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
S
SDZ
vs
S
Swiss Market Index
Over the past 12 months, SDZ has significantly outperformed Swiss Market Index, delivering a return of +43% compared to Swiss Market Index's +10% growth.
Stocks Performance
SDZ vs Swiss Market Index
Performance Gap
SDZ vs Swiss Market Index
Performance By Year
SDZ vs Swiss Market Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Sandoz Group AG
Glance View
Sandoz Group AG makes generic medicines and biosimilars, which are lower-cost versions of brand-name drugs and complex biologic medicines after patents expire. It also supplies certain established medicines such as antibiotics and other hospital and retail pharmacy products. The company sells to wholesalers, pharmacies, hospitals, and health systems that need reliable access to medicines at lower prices. Sandoz makes money by selling these finished drugs, usually through contracts with distributors and healthcare buyers. Its business depends on large-scale manufacturing, strong regulatory approval, and the ability to produce medicines that meet strict quality standards. For customers, the main appeal is a dependable source of approved drugs that help reduce prescription costs and expand patient access. What makes Sandoz different is its focus on off-patent medicines rather than discovering new drugs. That puts it in a part of the pharmaceutical industry where price, manufacturing expertise, and regulatory know-how matter more than research breakthroughs. It plays an important middle role in the healthcare system by turning complicated, expensive treatments into more affordable products that can be widely used.